# HDFC Life Insurance (NSE: HDFCLIFE) share analysis

Canonical: https://vestmind.in/stocks/hdfc-life-insurance  
Source: VestCall by Vestmind, price as of 14 October 2026.

> HDFC Life Insurance (NSE: HDFCLIFE) was trading at ₹552.4 on 14 October 2026. VestCall scores its business health 42/100 (weak). On valuation, the price sits in the “Valuation Premium” zone (₹538.48 and above) — above the modelled fair-value range. This is a reading of the evidence, not a buy or sell recommendation.

## Valuation zones

| Zone | Price band | Meaning |
| --- | --- | --- |
| Deeply Discounted | ₹480.91 – ₹510.05 | Furthest below the modelled fair-value range |
| Attractive Valuation | ₹510.05 – ₹523.53 | Below the modelled fair-value range |
| Fairly Valued | ₹523.53 – ₹538.48 | Inside the modelled fair-value range |
| Valuation Premium (current) | ₹538.48 and above | Above the modelled fair-value range |

## The case for and against

- Supports — Shareholding Quality 87/100
- Supports — Financial Strength 64/100
- Supports — Management Stability 64/100
- Needs proof — Growth 13/100
- Needs proof — Business Quality 26/100

## Key ratios

| Ratio | HDFC Life Insurance | Sector median |
| --- | --- | --- |
| P/E | 2.25x | — |
| P/S | 2.51x | — |
| Operating margin | 2.3% | — |
| Net margin | 2.5% | — |
| Current ratio | 1.03x | — |

## Bull, base and bear case (model outputs, not forecasts)

| Scenario | Modelled CAGR | Weight | Assumption |
| --- | --- | --- | --- |
| Bear | −4.1% | 21% | Growth decelerates to -0.1% and the multiple de-rates toward the cohort's trough. |
| Base | +4.7% | 54% | Earnings compound near the measured 4.7% and the multiple drifts toward its quality-adjusted warranted level. |
| Bull | +11.2% | 25% | Growth holds at 7.7% and the market pays the full premium the measured quality supports. |

## Questions

### Is HDFC Life Insurance overvalued or undervalued?

At ₹552.4, HDFC Life Insurance sits in VestCall’s “Valuation Premium” zone (₹538.48 and above): above the modelled fair-value range. Its valuation scores 91/100 (fair) against Unclassified peers. Zones describe where the price sits against modelled value; they are not an instruction to buy or sell.

### Is HDFC Life Insurance fundamentally strong?

VestCall scores HDFC Life Insurance’s business health 42/100 (weak). The strongest measured pillars are shareholding quality and financial strength. The ones that need proof are growth and business quality. Each pillar is computed from reported financials, and a pillar whose inputs were not reported is excluded rather than scored as zero.

### What is HDFC Life Insurance’s P/E ratio?

HDFC Life Insurance trades at a P/E of 2.25x, on VestCall’s latest read. A multiple only means something against the business it buys: the quality-adjusted fair value on this page weighs it against HDFC Life Insurance’s returns and growth.

### What are the risks of investing in HDFC Life Insurance?

The review triggers VestCall watches for HDFC Life Insurance are: revenue growth falls below the thesis floor (revenue cagr below 8%); drawdown from the 52-week high exceeds tolerance (drawdown from 52-week high at or beyond 25%); promoter holding drops materially (promoter holding below 47.54%, 3 points under the Mar 2026 filing). On the fundamentals, growth is the weakest measured pillar at 13/100. A trigger is a named condition that would change the reading, published so the case against the stock is as visible as the case for it.

### Is this a recommendation to buy or sell HDFC Life Insurance?

No. VestCall states where HDFC Life Insurance’s price sits against modelled value, what supports the case and what would break it, with every figure sourced. It does not issue buy, sell or hold calls or price targets. Vestmind is not a SEBI-registered investment adviser or research analyst, and nothing on this page is personalised investment advice.

---

Vestmind is not a SEBI-registered investment adviser or research analyst. This is research for information, not a recommendation or personalised investment advice.